BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35877228)

  • 1. Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.
    Tindale LC; Zhantuyakova A; Lam S; Woo M; Kwon JS; Hanley GE; Knoppers B; Schrader KA; Peacock SJ; Talhouk A; Dummer T; Metcalfe K; Pashayan N; Foulkes WD; Manchanda R; Huntsman D; Stuart G; Simard J; Dawson L
    Curr Oncol; 2022 Jun; 29(7):4632-4646. PubMed ID: 35877228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Chen LM; Richardson DL;
    Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and prevention of hereditary gynecologic cancers.
    Kehoe SM; Kauff ND
    Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in gynecologic cancer genetics evaluation.
    Hinchcliff EM; Bednar EM; Lu KH; Rauh-Hain JA
    Gynecol Oncol; 2019 Apr; 153(1):184-191. PubMed ID: 30711300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition in gynecologic cancers.
    Daniels MS; Lu KH
    Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
    Casey MJ; Bewtra C; Lynch HT; Snyder C; Stacy M; Watson P
    Fam Cancer; 2013 Dec; 12(4):719-40. PubMed ID: 23666231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future role of genetic screening in gynecologic malignancies.
    Ring KL; Garcia C; Thomas MH; Modesitt SC
    Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?
    Mitchell G; Schrader KA
    Surg Pathol Clin; 2016 Jun; 9(2):301-6. PubMed ID: 27241110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
    Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
    Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected medical interventions in women with a deleterious
    Hanley GE; McAlpine JN; Cheifetz R; Schrader KA; McCullum M; Huntsman D
    Curr Oncol; 2019 Feb; 26(1):e17-e23. PubMed ID: 30853805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of genetic syndromes predisposing to gynecologic cancers.
    Miesfeldt S; Lamb A; Duarte C
    Curr Treat Options Oncol; 2013 Mar; 14(1):34-50. PubMed ID: 23315239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic risk and gynecologic cancers.
    Holman LL; Lu KH
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):13-29. PubMed ID: 22244659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary gynecologic tumors and precision cancer medicine.
    Ogawa C; Hirasawa A; Ida N; Nakamura K; Masuyama H
    J Obstet Gynaecol Res; 2022 May; 48(5):1076-1090. PubMed ID: 35229413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
    Kurian AW; Kingham KE; Ford JM
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):23-33. PubMed ID: 25502425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Gynecologic Cancers In Relation to Genetic Predisposition.
    Lahiri Batra S
    Semin Oncol Nurs; 2019 Apr; 35(2):182-191. PubMed ID: 30871842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk assessment in breast and gynecologic malignancies- what's to know in 2024?
    Kamara D; Silver E; Niell-Swiller M
    Curr Opin Obstet Gynecol; 2024 Feb; 36(1):45-50. PubMed ID: 37792522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey.
    Kim M; Cheol Lim M; Ji Nam E; Huang D; Kim S; Jong Yoo H; Lee YY; Chang YJ;
    J Genet Couns; 2022 Apr; 31(2):546-553. PubMed ID: 34674340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.
    Ring KL; Modesitt SC
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):155-173. PubMed ID: 29428283
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Chung SH; Woldenberg N; Roth AR; Masamed R; Conlon W; Cohen JG; Joines MM; Patel MK
    Radiographics; 2020; 40(2):306-325. PubMed ID: 32031911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.